apologies for cross postings
 
We are designing a part-time MSc in Experimental Medicine at Oxford
University and would like to ask for your comments. A brief abstract of
the course is below. Please could you let us know if you find this
course of interest and if you would attend and/or refer a colleague? Any
information you have on the need for this type of training or who would
be interested, as well as the structure and content of the course would
be much appreciated. Sorry for the late notice, but if you would send
your comments by 21 November, it would greatly appreciated.
 
Thank you and best regards,
 
Annette Yang
Health Sciences
Professional Development Centre
Department for Continuing Education
Oxford University
[log in to unmask]
www.conted.ox.ac.uk/cpd
 
***
 
Programme: MSc in Experimental Medicine
Duration: 2 year, taught
Mode of Study: part-time, 8 modules (each are 5-day courses in Oxford)
spread over 2 years plus a project and dissertation Start Date: Autumn
2007
 
Who is it for?
National and international professional practitioners, including
clinicians, scientists, pharmacists and nurses, from the NHS, academia
and industry, in the multidisciplinary sciences that contribute to this
constantly evolving field of modern molecular medicine who want to
obtain a better understanding of cancer, diabetes, cardiac,
haematological and infectious disease.
 
Course Content
The University of Oxford has designed a part-time MSc in Experimental
Medicine that brings together specialists to deliver a stimulating
course demonstrating the application of new technologies in rational,
mechanism-oriented clinical-trial designs, uniting the fundamental
precepts of clinical pharmacology and medical statistics with emergent
sciences of molecular biology, pharmacogenetics, and structural
genomics.
 
The aim of the MSc programme is to provide students with the necessary
training and practical experience to enable them to understand the
principles that underpin clinical research, and to enable them to
translate that understanding into good clinical practice. This will be
important in enhancing the quality of experimental medicine in the
institutions to which they belong. Specifically, at the end of the
course all successful students will understand the following core
principles:
- how drugs are developed and marketed
- important aspects of drug regulation
- pharmaceutical factors that affect drug therapy
- pharmacokinetics and drug metabolism
- pharmacogenetics
- pharmacodynamics (pharmacological actions of drugs) and the principles
of pharmacokinetic-pharmacodynamic modelling
- adverse drug reactions, drug interactions, and pharmacovigilance
- clinical trial design for a range of novel therapeutics (an imaging
agents)
- laboratory assays used to support trial end-points
- application of statistics to medicine
- use of non invasive imaging in drug development
 
Optional modules could include:
- molecular approaches to gene therapy and immunotherapy
- principles of cancer chemotherapy
- experimental therapeutics in diabetes and metabolic disorders
- drug therapy in psychiatry
- drug therapy in cardiovascular medicine
- structural genomics and drug discovery
 

___________________________________________________________
List membership settings and archives:
http://www.jiscmail.ac.uk/lists/community-health.html
List videoconferencing:
http://www.groupintervisual.net/hosting/community-health/
List help via e-mail:
[log in to unmask]